- Home
- ORKT vs RNXT Comparison
ORKT vs RNXT Comparison
Compare ORKT & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORKT
- RNXT
- Stock Information
- Founded
- ORKT 2003
- RNXT 2012
- Country
- ORKT Singapore
- RNXT United States
- Employees
- ORKT N/A
- RNXT N/A
- Industry
- ORKT
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- ORKT
- RNXT Health Care
- Exchange
- ORKT NYSE
- RNXT Nasdaq
- Market Cap
- ORKT N/A
- RNXT 44.6M
- IPO Year
- ORKT 2024
- RNXT 2021
- Fundamental
- Price
- ORKT $0.58
- RNXT $1.36
- Analyst Decision
- ORKT Strong Buy
- RNXT Strong Buy
- Analyst Count
- ORKT 1
- RNXT 2
- Target Price
- ORKT $5.00
- RNXT $7.25
- AVG Volume (30 Days)
- ORKT 266.3K
- RNXT 147.2K
- Earning Date
- ORKT 01-01-0001
- RNXT 08-12-2025
- Dividend Yield
- ORKT N/A
- RNXT N/A
- EPS Growth
- ORKT N/A
- RNXT N/A
- EPS
- ORKT N/A
- RNXT N/A
- Revenue
- ORKT $2,962,282.00
- RNXT $240,000.00
- Revenue This Year
- ORKT $9.63
- RNXT $3,186.05
- Revenue Next Year
- ORKT N/A
- RNXT $291.93
- P/E Ratio
- ORKT N/A
- RNXT N/A
- Revenue Growth
- ORKT N/A
- RNXT N/A
- 52 Week Low
- ORKT $0.40
- RNXT $0.75
- 52 Week High
- ORKT $8.00
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- ORKT N/A
- RNXT 55.76
- Support Level
- ORKT N/A
- RNXT $1.27
- Resistance Level
- ORKT N/A
- RNXT $1.42
- Average True Range (ATR)
- ORKT 0.00
- RNXT 0.07
- MACD
- ORKT 0.00
- RNXT -0.02
- Stochastic Oscillator
- ORKT 0.00
- RNXT 62.50
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.